IL-AIT-WORLDWIDE
28.8.2024 17:04:29 CEST | Business Wire | Press release
Global supply chain solutions leader, AIT Worldwide Logistics, is pleased to announce the launch of its new artificial intelligence (AI) and data science team, a corporate-level department created to amplify the organization’s investment in data. The team will set the stage for the future implementation of next-generation AI tools to further enhance the company’s robust customer interface. To lead the new group, AIT’s Patrick Chew has been appointed to vice president, AI and data science.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240828389373/en/
Data is an integral pillar at AIT, with the new AI and data science team working to enable a new era of dramatic growth for the company. (Photo: Business Wire)
“AIT is continually looking towards the future,” said Chairman and Chief Executive Officer, Vaughn Moore. “With the establishment of the AI and data science team, the company is prepared to capitalize on generative AI, natural language processing, machine learning, large language models, and other advancing technologies.”
Over the course of 25 years, Chew has helped numerous Fortune 500 companies improve their business intelligence, analytics, and data enablement. He most recently served as the head of Caterpillar’s enterprise data governance office. Since joining the company in January 2024, Chew has been responsible for directing data enablement efforts. He reports to AIT’s President and Chief Operating Officer, Keith Tholan.
“AIT leadership has made a significant commitment to transform our data, and we are delighted to have Patrick in a role where he can leverage his vast experience to guide our ongoing data journey for the primary benefit of our customers and teammates,” Tholan said.
“Data is a common denominator that informs and impacts every aspect of the business,” he added. “And at AIT, our investment in taking data enablement to the next level clearly signals that data is an integral pillar of the organization, with the new AI and data science team working to enable a new era of dramatic growth for the company.”
The AI and data science group is comprised of three key teams:
- Data enablement – leading a disciplined, firmwide process to reorganize existing data strongholds into next-gen-compatible assets that will build new levels of trust with stakeholders through increased efficiency and ever-improving solutions
- AI governance and data science – developing new AI business features with an emphasis on heightened accuracy and privacy protections for customers and teammates as the technology continues to mature and evolve
- Business intelligence and analytics – providing dedicated, centralized reporting and visualization needs across the organization
The AI and data science team is implementing a regimented approach to transform data across AIT’s global network, including steps to redefine core domains and enhance time-tested workflows. Data management based on a newly configured single version of truth will be well-positioned to support powerful new key performance indicators.
“Treating data as an asset involves rigorous efforts to reorganize and harness millions of inputs, which will be applied in meaningful ways to enhance business intelligence, boost efficiency and spur innovation,” Chew said.
“Ambitiously raising the bar to loftier heights for data quality and governance ultimately improves outcomes for stakeholders as we continue to earn our customers’ trust,” he added. “Our AI and data science initiative will further differentiate AIT with shippers and investors when compared to others in the freight forwarding industry.”
About AIT Worldwide Logistics
AIT Worldwide Logistics is a global freight forwarder that helps companies grow by expanding access to markets all over the world where they can sell and/or procure their raw materials, components and finished goods. For more than 40 years, the Chicago-based supply chain solutions leader has relied on a consultative approach to build a global network and trusted partnerships in nearly every industry, including aerospace, automotive, consumer retail, energy, food, government, high-tech, industrial, life sciences and marine. Backed by scalable, user-friendly technology, AIT’s flexible business model customizes end-to-end deliveries via sea, air, ground and rail — on time and on budget. With expert teammates staffing more than 150 worldwide locations in Asia, Europe and North America, AIT’s full-service options also include customs clearance, warehouse management and white glove services. Learn more at www.aitworldwide.com.
Our Mission
At AIT, we vigorously seek opportunities to earn our customers’ trust by delivering exceptional worldwide logistics solutions while passionately valuing our co-workers, partners and communities.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828389373/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enhertu® Approved in the EU as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer27.10.2026 08:30:00 CET | Press release
Approval based on DESTINY-Breast05 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 First EU approval of Enhertu in the curative-intent early breast cancer setting Third approval for Enhertu in the EU in four months Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for
Avanzanite Bioscience Expands UK Presence and Appoints Sarah O’Connell as Country Manager27.10.2026 08:00:00 CET | Press release
Avanzanite Bioscience B.V., a European pharmaceutical company focused on rare diseases, today announced the expansion of its United Kingdom (UK) presence and the appointment of Sarah O’Connell as UK Country Manager. The move strengthens Avanzanite’s long-term commitment to the UK and its ability to help eligible patients access innovative rare disease medicines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027035012/en/ Sarah O'Connell, Country Manager, UK, Avanzanite Bioscience “The UK is essential to our ambition of building Avanzanite into a European rare disease champion. We feel a deep and lasting connection to this market and there is no European reach without the UK,” said Adam Plich, co-founder and CEO, Avanzanite Bioscience. “At a time when parts of the life sciences sector are reassessing their investment and presence in the UK, we are choosing to commit and build for the long term. With Sarah’s extensive rare
LTM Secures Strategic Engagement with a Global Banking and Financial Services Firm27.10.2026 05:30:00 CET | Press release
LTM, the Business Creativity partner to the world's largest enterprises, has secured a strategic engagement with a large global banking and financial services firm, further strengthening its position as a trusted technology and transformation partner to leading financial institutions. This two-year engagement is already underway with an option to extend for an additional year and has a potential value of up to USD 100 million. The engagement reflects the continued expansion of LTM’s relationship with the client and its growing role in advancing strategic technology programmes and supporting supplier consolidation initiatives across the organization. Under the agreement, LTM will serve as a preferred partner driving the consolidation and delivery of strategic technology requirements across key wealth, personal banking, and global functions. The engagement will leverage LTM’s deep banking-domain expertise, engineering excellence, and global delivery capabilities to support the client’s t
DDN Selected to Modernize Research Data Infrastructure at UNSW Sydney26.10.2026 22:30:00 CET | Press release
DDN EXAScaler and Arcitecta Mediaflux will replace 11 legacy storage systems, simplifying access to research data while balancing performance and cost DDN, the global leader in AI and data intelligence solutions, today announced that UNSW Sydney has selected DDN to deliver a new research data storage environment as part of the university’s Research Data Experience (RDE) program. Working with Australian software company Arcitecta, DDN will combine its EXAScaler parallel file system with Arcitecta’s Mediaflux® data management platform to help researchers spend less time managing data and more time using it. Following an extensive 18-month evaluation, UNSW selected an integrated approach that will replace 11 legacy storage systems with a coordinated environment for high-performance storage and enterprise data management. The decision reflects a broader challenge facing research-intensive institutions: how to support rapidly expanding scientific datasets while simplifying infrastructure, i
Agent Assurance by TestMu AI Is Now Generally Available, Letting Teams Test What Their AI Agents Actually Change26.10.2026 16:15:00 CET | Press release
The trial includes 4,000 credits and four concurrent runs, so a team can generate functional and adversarial suites from its own agent's docs and endpoint, with code optional, and gate CI on evidence-backed verdicts without booking a demo. TestMu AI (formerly LambdaTest), the world's first Agentic AI-powered Quality Engineering platform, today announced the general availability of Agent Assurance. Agent Assurance tests AI agents that take actions, such as calling tools, writing files, and changing records, by checking what a run actually changed rather than what the agent says it did. Any team can now create a TestMu AI account and run it against its own agent without booking a demo first. Agent Assurance launched on August 17, 2026, behind a waitlist and a guided onboarding session. Since then, Rook, the CLI that runs Agent Assurance, has shipped a steady run of releases, shaped by feedback from early teams. Agent evaluation has mostly graded the final reply, and that reply can be wro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom